+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Single-use Bioprocessing Market - Global Forecast 2026-2032- Product Image
Single-use Bioprocessing Market - Global Forecast 2026-2032- Product Image
Sale

Single-use Bioprocessing Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336436
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Single-use Bioprocessing Market is projected to reach USD 24.11 Billion in 2026. It is expected to continue growing at a CAGR of 16.26%, reaching USD 59.77 Billion by 2032.

Single-use bioprocessing has moved from a niche manufacturing option to a mainstream operating model for biologics, vaccines, biosimilars, and advanced therapies. Disposable bioreactors, bags, tubing assemblies, connectors, filtration systems, sterile sampling technologies, and single-use sensors reduce cleaning validation burden, shorten changeover time, and support closed processing in GMP environments.

The industry is being shaped by the global expansion of monoclonal antibodies, mRNA platforms, cell and gene therapies, and intensified upstream and downstream processing. Adoption is also supported by documented reductions in water-for-injection demand, clean-in-place and steam-in-place infrastructure, and cross-contamination risk, while buyers continue to scrutinize extractables and leachables, resin security, supplier redundancy, particulate control, and plastic waste management.

Transformative Shifts in the Landscape

The single-use bioprocessing landscape is shifting toward modular, multiproduct, and digitally connected facilities. Manufacturers are increasingly combining single-use bioreactors, chromatography skids, sterile transfer systems, single-use mixers, depth filtration, and automation platforms to improve campaign flexibility and reduce facility buildout time.

A second major shift is the movement from open or semi-open workflows to closed, integrated processing. This transition is especially relevant for high-value biologics and personalized therapies where sterility assurance, rapid batch release, and manufacturing agility are critical. Standardization initiatives from industry groups, pharmacopoeias, and regulators are also improving confidence in materials characterization, component qualification, extractables and leachables testing, and supplier change control.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of single-use bioprocessing by improving process understanding, deviation detection, and capacity planning. AI-enabled analytics can support bioreactor control, predictive maintenance, raw-material forecasting, visual inspection, electronic batch record review, and process monitoring when implemented within validated, data-integrity-compliant quality systems.

The strongest near-term impact is in hybrid decision support rather than fully autonomous manufacturing. Digital twins, multivariate analysis, and machine learning models can help teams link sensor data, media performance, mixing conditions, cell-culture behavior, and filtration performance to critical quality attributes. However, adoption depends on robust model governance, audit trails, cybersecurity, human oversight, and alignment with FDA, EMA, ICH Q9, ICH Q10, ICH Q12, and GAMP principles.

Key Regional Insights

Asia-Pacific is gaining strategic importance as China, India, Japan, South Korea, Singapore, and Australia expand biologics, biosimilar, vaccine, and advanced therapy manufacturing capacity. The region benefits from contract development and manufacturing momentum, public health investment, skilled bioprocessing talent, and cost-efficient production ecosystems, although firms must manage supplier qualification, resin traceability, cold-chain reliability, and regulatory harmonization across diverse markets.

North America remains a leading demand center due to the United States and Canada’s concentration of biologics developers, CDMOs, cell therapy innovators, clinical trial infrastructure, and advanced manufacturing programs. Latin America, led by Brazil and Mexico, is adopting single-use technologies to strengthen vaccine resilience, public-sector biologics production, and biosimilar manufacturing. Europe maintains strong demand through Germany, France, Italy, Spain, the United Kingdom, and broader European quality expectations, with adoption shaped by EMA oversight, EU GMP expectations, advanced therapy activity, and rising sustainability scrutiny around disposable plastics.

The Middle East is emerging through GCC investments in pharmaceutical localization, with Saudi Arabia and the United Arab Emirates prioritizing healthcare security, vaccine access, and biomanufacturing capability. Africa is earlier in adoption but increasingly relevant as regional vaccine manufacturing, fill-finish capacity, workforce development, and technology-transfer initiatives develop in markets such as South Africa, Egypt, Rwanda, Senegal, and Morocco.

Key Group Insights

ASEAN markets are increasingly relevant for single-use bioprocessing because Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines are building biotechnology, vaccine, and pharmaceutical manufacturing ecosystems. The group’s advantage lies in regional trade connectivity, growing healthcare demand, government support for life sciences investment, and the ability to serve both clinical-stage and commercial manufacturing needs through flexible, modular bioprocessing infrastructure.

The GCC is using healthcare diversification strategies to build local production capacity, reduce import dependency, and support vaccine and biologics access, while the European Union provides a highly regulated and innovation-oriented environment shaped by EMA oversight, EU GMP expectations, pharmacovigilance discipline, and sustainability policy. BRICS countries are important because Brazil, Russia, India, China, and South Africa combine large patient populations with rising biopharmaceutical manufacturing ambitions, biosimilar activity, public health programs, and policy support for localized production.

G7 countries remain central to technology development, regulatory precedent, advanced therapy commercialization, and high-value biologics manufacturing. NATO members, many of which overlap with G7 and EU economies, also influence biomanufacturing resilience through supply-chain security, pandemic preparedness, strategic stockpiling, dual-use manufacturing readiness, and defense-adjacent medical countermeasure programs.

Key Country Insights

The United States leads in biologics innovation, CDMO capacity, regulatory science, and cell and gene therapy commercialization, while Canada benefits from vaccine investments, academic translation, and growing domestic biomanufacturing capability. Mexico is strengthening pharmaceutical manufacturing links with North American supply chains and nearshoring strategies, and Brazil remains Latin America’s most important biologics and public-health production market, supported by vaccine capabilities and biosimilar demand.

In Europe, the United Kingdom supports advanced therapy development, clinical manufacturing, and regulatory flexibility, Germany anchors engineering, automation, high-specification bioprocess equipment demand, and biologics manufacturing, and France is expanding vaccine and biologics capacity. Italy and Spain are important for contract manufacturing, injectable drug production, and sterile processing, while Russia maintains localized biologics ambitions despite geopolitical, financing, and supply constraints affecting access to advanced components and validation support.

In Asia-Pacific, China has scaled biologics and biosimilar development rapidly with expanding domestic manufacturing capability, India combines vaccine leadership with biosimilar production and CDMO growth, and Japan emphasizes quality, automation, process control, and specialty biologics. South Korea has become a global biologics manufacturing hub with strong large-scale biomanufacturing capabilities, and Australia supports clinical-stage biomanufacturing, translational research, advanced therapy development, and regional supply resilience.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a dual-sourcing strategy for critical single-use assemblies, films, filters, connectors, tubing, bags, and sensors. Supplier qualification must extend beyond price to include resin traceability, change-notification discipline, extractables and leachables packages, particulate controls, business continuity planning, and regional logistics resilience.

Manufacturers should also build quality-by-design frameworks that integrate closed processing, standardized assemblies, validated automation, operator training, and real-time data capture. Sustainability should be addressed through lifecycle assessment, waste segregation, take-back programs where available, responsible incineration or recycling routes where technically feasible, and facility designs that quantify reductions in water, energy, cleaning chemicals, and cleaning validation effort.

Research Methodology

This executive summary is developed using secondary research grounded in recognized public sources and industry standards, including regulatory guidance from FDA, EMA, WHO, ICH, USP, ISO, and pharmacopeial frameworks relevant to single-use systems. It also considers published industry practices from bioprocessing associations, GMP expectations, technology-transfer guidance, and documented technology adoption across biologics, vaccines, biosimilars, and advanced therapies.

The analysis applies a triangulated approach that reviews demand drivers, manufacturing trends, regional policy signals, supply-chain considerations, regulatory expectations, and technology maturity. Insights are validated against observable industry behavior, including capacity expansions, CDMO strategies, quality-system requirements, and the operational characteristics of single-use bioreactors, filtration, mixing, storage, aseptic sampling, sterile connectors, and closed transfer systems.

Conclusion

Single-use bioprocessing is becoming a core enabler of flexible, scalable, and contamination-controlled biomanufacturing. Its role is expanding as biologics pipelines diversify and manufacturers seek faster facility deployment, smaller campaign footprints, reduced cleaning burden, and improved multiproduct agility.

The next phase of industry adoption will depend on disciplined quality management, resilient supplier ecosystems, AI-enabled process intelligence, and credible sustainability practices. Organizations that combine single-use platforms with validated automation, regional supply strategies, robust regulatory documentation, and lifecycle-based waste management will be best positioned to capture long-term operational value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Single-use Bioprocessing Market, by Offering
7.1. Introduction
7.2. Individual Components
7.2.1. Bags & Containers
7.2.2. Connectors
7.2.3. Filtration & Separation Devices
7.2.4. Pumps & Flow Control
7.2.5. Sampling Devices & Accessories
7.2.6. Sensors & Probes
7.2.7. Tubing
7.2.7.1. Polyethylene (PE)
7.2.7.2. Polypropylene (PP)
7.2.7.3. Polyvinyl Chloride (PVC)
7.2.7.4. Silicone
7.3. Single-Use Subassemblies
7.3.1. Bioreactor / Process Assemblies
7.3.2. Media Transfer Assemblies
7.3.3. Sampling Assemblies
7.3.4. Tubing Assemblies / Manifolds
8. Single-use Bioprocessing Market, by Workflow Stage
8.1. Introduction
8.2. Downstream Processing
8.3. Fill-Finish Operations
8.4. Quality Control & Analytics
8.5. Upstream Processing
9. Single-use Bioprocessing Market, by Bioprocess Mode
9.1. Introduction
9.2. Batch
9.3. Fed-Batch
9.4. Perfusion
10. Single-use Bioprocessing Market, by Single-use Subassemblies
10.1. Introduction
10.2. Aseptic Transfer Sets
10.3. Filling Subassemblies
10.4. Manifold Assemblies
10.5. Sampling Subassemblies
10.6. Tubing Assemblies
11. Single-use Bioprocessing Market, by Manufacturing Processes
11.1. Introduction
11.2. 3D Printing
11.3. Adhesive Bonding
11.4. Blow Molding
11.5. Extrusion
11.6. Injection Molding
11.7. Overmolding
11.8. RF Welding
11.9. Thermoforming
11.10. Ultrasonic Welding
12. Single-use Bioprocessing Market, by Application
12.1. Introduction
12.2. Aseptic Filling
12.3. Cell Culture
12.4. Filtration
12.5. Mixing
12.6. Purification
12.7. Sampling
12.8. Storage
13. Single-use Bioprocessing Market, by End User
13.1. Introduction
13.2. Academic & Research Institutes
13.3. Contract Manufacturing Organizations & Contract Research Organizations
13.4. Pharmaceutical & Biotechnology Companies
14. Single-use Bioprocessing Market, by Region
14.1. Europe
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Single-use Bioprocessing Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Single-use Bioprocessing Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. United Kingdom
16.5. Japan
16.6. Canada
16.7. India
16.8. France
16.9. Brazil
16.10. Mexico
16.11. Italy
16.12. Australia
16.13. Russia
16.14. Spain
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. AdvantaPure by NewAge Industries
18.2. Agilitech
18.3. Aseptic Group
18.4. Avantor, Inc.
18.5. Bionet Servicios Técnicos SL
18.6. BioPharma Dynamics Ltd.
18.7. CellBios Healthcare & Lifesciences Pvt. Ltd.
18.8. Compagnie de Saint-Gobain
18.9. Corning Incorporated
18.10. Cytiva by Danaher Corporation
18.11. Entegris, Inc.
18.12. Eppendorf SE
18.13. Foxx Life Sciences
18.14. Freudenberg Group
18.15. Getinge AB
18.16. Kuehne + Nagel International AG
18.17. Lonza Group AG Ltd.
18.18. Meissner Corporation
18.19. Merck KGaA
18.20. Mettler-Toledo International Inc.
18.21. Parker-Hannifin Corporation
18.22. PBS Biotech, Inc.
18.23. PharmNXT Biotech
18.24. PSG Dover by Dover Corporation
18.25. Repligen Corporation
18.26. SaniSure
18.27. Sartorius AG
18.28. Satake Multimix Corporation
18.29. Single Use Support GmbH
18.30. Tekni-Plex, Inc.
18.31. Thermo Fisher Scientific Inc.
18.32. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
List of Figures
FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CONNECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CONNECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CONNECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SENSORS & PROBES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SENSORS & PROBES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SENSORS & PROBES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TUBING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TUBING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TUBING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SILICONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BATCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BATCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL BATCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FED-BATCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FED-BATCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL FED-BATCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PERFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PERFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PERFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL 3D PRINTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL 3D PRINTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL 3D PRINTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ADHESIVE BONDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ADHESIVE BONDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ADHESIVE BONDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL BLOW MOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL BLOW MOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL BLOW MOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL EXTRUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL EXTRUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL EXTRUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL INJECTION MOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL OVERMOLDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL OVERMOLDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL OVERMOLDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL RF WELDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL RF WELDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL RF WELDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL THERMOFORMING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL THERMOFORMING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL THERMOFORMING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ASEPTIC FILLING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL ASEPTIC FILLING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ASEPTIC FILLING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL FILTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL FILTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL FILTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL MIXING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL MIXING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL MIXING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PURIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PURIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PURIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL SAMPLING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL SAMPLING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL SAMPLING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL STORAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL STORAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL STORAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 157. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 158. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 159. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 161. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 162. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 163. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 164. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 165. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 201. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 203. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 204. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 205. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 206. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 207. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 208. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 224. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 225. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 226. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 227. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 228. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 229. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 230. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 231. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 235. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 236. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 237. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 238. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 239. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 240. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 241. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 242. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 257. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 258. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 259. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 260. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 261. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 262. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 263. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 264. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 268. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 269. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 270. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 271. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 272. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 273. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 274. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 275. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 278. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 279. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 280. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 281. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 282. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 283. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 284. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 285. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 286. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 300. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 302. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 303. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 304. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 305. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 306. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 307. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 308. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 309. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 313. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 314. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 315. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 316. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 317. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 318. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 319. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 320. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 321. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 328. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 333. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 334. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 335. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 336. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 337. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 338. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 339. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2017-2032 (USD MILLION)
TABLE 340. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 341. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2017-2032 (USD MILLION)
TABLE 342. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 343. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 346. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2017-2032 (USD MILLION)
TABLE 347. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2017-2032 (USD MILLION)
TABLE 348. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2017-2032 (USD MILLION)
TABLE 349. CANAD

Companies Mentioned

  • AdvantaPure by NewAge Industries
  • Agilitech
  • Aseptic Group
  • Avantor, Inc.
  • Bionet Servicios Técnicos SL
  • BioPharma Dynamics Ltd.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Compagnie de Saint-Gobain
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Eppendorf SE
  • Foxx Life Sciences
  • Freudenberg Group
  • Getinge AB
  • Kuehne + Nagel International AG
  • Lonza Group AG Ltd.
  • Meissner Corporation
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • Parker-Hannifin Corporation
  • PBS Biotech, Inc.
  • PharmNXT Biotech
  • PSG Dover by Dover Corporation
  • Repligen Corporation
  • SaniSure
  • Sartorius AG
  • Satake Multimix Corporation
  • Single Use Support GmbH
  • Tekni-Plex, Inc.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.11 Billion
Forecasted Market Value ( USD ) by 2032 $ 59.77 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Single-use Bioprocessing Sensors & Probes Market - Global Forecast 2026-2032 - Product Image

Single-use Bioprocessing Sensors & Probes Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Upstream Bioprocessing Market - Global Forecast 2026-2032 - Product Image

Upstream Bioprocessing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Single-Use Bioprocessing - Global Strategic Business Report - Product Image

Single-Use Bioprocessing - Global Strategic Business Report

  • Report
  • 217 Pages
  • Global
From
Upstream Bioprocessing - Global Strategic Business Report - Product Image

Upstream Bioprocessing - Global Strategic Business Report

  • Report
  • 166 Pages
  • Global
From
Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030 - Product Image

Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030

  • Report
  • 573 Pages
  • Global
From

About the Single Use Bioprocessing Market

The Single Use Bioprocessing market is a subset of the biotechnology industry that focuses on the development and production of biopharmaceuticals using disposable components. This technology is used to reduce the risk of cross-contamination and simplify the manufacturing process. Single use bioprocessing systems are designed to be used for a single batch of product, and then disposed of. This technology is used in the production of vaccines, monoclonal antibodies, and other biopharmaceuticals. Single use bioprocessing systems are becoming increasingly popular due to their cost-effectiveness and scalability. This technology is also beneficial for companies that need to quickly scale up production for new products. Some companies in the Single Use Bioprocessing market include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher Corporation, and GE Healthcare. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.